Surrey Heartlands

Joint Formulary & PAD

Hyoscine hydrobromide - Hypersalivation in adults

You are here : Home > Formulary Search > Hyoscine hydrobromide - Hypersalivation in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Patches
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Off-label use.
 

Status 2

Green (see narrative)
Formulations :
  • Oral solution
  • Oral suspension
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
100mcg per ml. Unlicensed formulation.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Hyoscine hydrobromide
Indication :
Hypersalivation in adults
Group Name :
Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea
Brand Names Include :
Scopoderm patch, Kwells
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Hyoscine hydrobromide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hypersalivation in adults.

Committee Recommendations (1)

04 Dec 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.